2025 Speakers

Dr. Yaghoubi is Co-Founder and CEO of PathMaker Neurosystems, and has over 20 years of experience in the creation, operations and financing of life science companies. At PathMaker, he is leading the development of a breakthrough approach to treating ALS using non-invasive neuromodulation, and serves as Principal Investigator on US Department of Defense, Muscular Dystrophy Association and NIH awards. Dr. Yaghoubi previously founded and served as CEO of Symbiotix Biotherapies, an early microbiome company emerging from Harvard Medical School. Earlier, he was the first employee at BIND Biosciences (Nasdaq:BIND) and Selecta Biosciences (Nasdaq:SELB), where he worked with the MIT founders to launch these targeted nanoparticle companies. Previously, he was an investor at Zero Stage Capital, and completed an internship at Advent International. He was a Health Care Entrepreneurship Fellow at Boston University, and earlier, was a surgery resident at Lenox Hill Hospital. Dr. Yaghoubi received an M.D. and Ph.D. in Molecular Pharmacology from the combined degree program at Boston University School of Medicine. His doctorate work on the development of high-throughput automated electrophysiological systems resulted in five issued patents, received one of the University's highest awards for dissertational research, and was the basis of a venture-backed neuroscience company.